Publications by authors named "Zuan Lin"

Claim this Profile
G
Ginsenoside Rb inhibits cardiomyocyte apoptosis and rescues ischemic myocardium by targeting Caspase-3.
Chenhui Zhong, Liyuan Ke, Fen Hu, Zuan Lin, Shuming Ye, Zan Lin

J Pharm Anal· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of virtual screening and proteomics reveals potential targets and pathways for ginsenoside Rg against myocardial ischemia.
Rongfang Xie, Chenlu Li, Chenhui Zhong, Zuan Lin, Shaoguang Li

J Ginseng Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy.
Li-Na He, Haifeng Li, Wei Du, Sha Fu, Linfeng Luo, Zuan Lin

iScience· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer.
Wei Du, Chen Chen, Lin-Feng Luo, Li-Na He, Yixing Wang, Zuan Lin

J Cancer Res Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
Xuanye Zhang, Yixin Zhou, Hualin Chen, Chen Chen, Zuan Lin

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies.
Jinhui Xue, Haipeng He, Zuan Lin, Yuehan Wu, Yuehao Lin

Cancer Chemother Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CT-based radiomics model to predict subsequent brain metastasis in patients with ALK-rearranged non-small cell lung cancer undergoing crizotinib treatment.
Yongluo Jiang, Yixing Wang, Sha Fu, Tao Chen, Yixin Zhou, Zuan Lin

Thorac Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus.
Zuan Lin, Xuanye Zhang, Yixin Zhou, Chen Chen, Li-Na He

Cancer Immunol Immunother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus.
Zuan Lin, Xuanye Zhang, Yixin Zhou, Chen Chen, Li-Na He

Cancer Immunol Immunother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing number of target lesions for RECIST1.1 to predict survivals in patients with advanced non-small-cell lung cancer undergoing anti-PD1/PD-L1 monotherapy.
Li-Na He, Tao Chen, Sha Fu, Chen Chen, Yongluo Jiang, Zuan Lin

Lung Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress (2015-2020) in the investigation of the pharmacological effects and mechanisms of ginsenoside Rb, a main active ingredient in Meyer.
Zuan Lin, Rongfang Xie, Chenhui Zhong, Jianyong Huang, Peiying Shi

J Ginseng Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer.
Chen Chen, Yixin Zhou, Xuanye Zhang, Yuhong Wang, Li-Na He, Zuan Lin

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Research Progress (2015-2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA.
Chenhui Zhong, Zuan Lin, Liyuan Ke, Peiying Shi, Shaoguang Li, Xinhua Lin

Front Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the potential anti-COVID-19 active ingredients in (Burm. F.) Nees by combination of network pharmacology, molecular docking, and molecular dynamics.
Rongfang Xie, Zuan Lin, Chenhui Zhong, Shaoguang Li, Bing Chen

RSC Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and early changes in circulating Serum Amyloid A (SAA) predict survival outcomes in advanced non-small cell lung cancer patients treated with Anti-PD-1/PD-L1 monotherapy.
Li-Na He, Sha Fu, Xuanye Zhang, Qiaozhen Hu, Wei Du, Zuan Lin

Lung Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy.
Xuanye Zhang, Dan Tian, Yue Chen, Chen Chen, Li-Na He, Zuan Lin

Transl Lung Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy.
Li-Na He, Xuanye Zhang, Haifeng Li, Tao Chen, Chen Chen, Zuan Lin

Front Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential mechanism of action of extract injection against cardiovascular diseases revealed by combination of HPLC-Q-TOF-MS, virtual screening and systems pharmacology approach.
Rongfang Xie, Zhenzhen Liu, Zuan Lin, Peiying Shi, Bing Chen, Xinhua Lin

RSC Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum.
Chen Chen, Xuanye Zhang, Yixin Zhou, Sha Fu, Zuan Lin

Cancer Manag Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Integrated Pharmacokinetic Study of an Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats.
Peiying Shi, Yunjiao Xie, Rongfang Xie, Zuan Lin, Hong Yao

Front Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple fluorescence assay for trypsin through a protamine-induced carbon quantum dot-quenching aggregation platform.
Yiping Chen, Zuan Lin, Chenfang Miao, Qianqian Cai, Fenglan Li, Xinhua Lin

RSC Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Chen Chen, Yixin Zhou, Xuanye Zhang, Sha Fu, Zuan Lin

Cancer Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma.
Zuan Lin, Sha Fu, Yixin Zhou, Xuanye Zhang, Chen Chen

Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition.
Xuanye Zhang, Yixin Zhou, Chen Chen, Wenfeng Fang, Xiuyu Cai, Zuan Lin

J Immunother Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy.
Yixin Zhou, Zuan Lin, Xuanye Zhang, Chen Chen, Hongyun Zhao

J Immunother Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis